PE Deals

Flexpoint-backed CHS buys Stadco Polyproducts and Respan Products

The two acquisitions will result in expanded Ontario manufacturing capabilities for medical products, CHS said.

-
  • CHS is a medical device maker and distributor
  • The company’s Oakville plant is currently undergoing a $3.8 million upgrade
  • US private equity firm Flexpoint Ford acquired CHS in April 2021

Flexpoint Ford’s portfolio company Canadian Hospital Specialities (CHS), a medical device maker and distributor, has acquired two companies, Mississauga, Ontario-based Stadco Polyproducts and Erin, Ontario-based Respan Products.

The two acquired companies both have manufacturing plants located in Mississauga and Erin respectively. They will be additions to CHS’ existing Oakville, Ontario plant which is currently undergoing a $3.8 million upgrade. Earlier this year CHS received $1.9 million from the Ontario government to help CHS modernize and expand the plant.

Flexpoint Ford was founded in 2005 and has offices in both Chicago and New York. It is a private equity firm that has raised more than $5 billion in capital. It looks to invest in companies in the financial services and healthcare sectors. Since its formation, it has completed investments in over 40 companies.

Flexpoint acquired CHS in April 2021. Canadian junior capital provider Penfund made a second-lien debt investment at the time to support the acquisition.

“These acquisitions provide us with the ability to manufacture and supply a greater volume of Ontario-produced medical products for the Canadian and US markets and provide an alternative for healthcare customers to avoid some of the current challenges associated with sourcing products from overseas,” states Mike Canzoneri, president and CEO of CHS. “The acquisitions also reinforce CHS’ continued commitment to make strategic investments in Ontario’s manufacturing infrastructure and personnel.”